Infections Requiring Prolonged Duration (>10 Days) of Vancomycin
Conditions
Brief summary
This study is being carried out to find out whether there is reduction in vancomycin-induced kidney injury (nephrotoxicity) when vancomycin is given as intermittent versus continuous infusion. This study will recruit 220 subjects from 2 hospitals over a period of 3 years. Participants are invited if they have an infection that requires prolonged vancomycin therapy (\> more than 10 days).
Interventions
24-hour continuous infusion of vancomycin
Sponsors
Study design
Eligibility
Inclusion criteria
* Adults aged 21-80 years * Documented infection requiring prolonged (\> 10 days) of vancomycin therapy * Creatinine clearance \> 50 ml/min (using Cockroft-Gault equation)
Exclusion criteria
* Patient already received 7 days or more of vancomycin therapy * Pregnancy * Severe burns \> 40% body surface area * Spinal cord injuries * Participation in another interventional trial in previous 30 days * Inability to obtain informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| nephrotoxicity | occurring any time while on vancomycin treatment up to 14 days post treatment completion | nephrotoxicity as defined by the acute kidney injury network (AKIN) criteria using only serum creatinine criteria |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| biomarkers for detection of early nephrotoxicity | measured weekly from the date of randomization until 14 days post completion of vancomycin | serum and urine NGAL and cystatin C |
Countries
Singapore